Table 3.
Outcome Measures | Pre-Post | Unmatched Treatment | Group Effect | Interaction | Time Effect (n=82 with | |
---|---|---|---|---|---|---|
Groups | (F df) | (F df) | complete data) (F df) | |||
Opposite | EBC | Intention to Treat* (n=96) | ||||
Mean | Mean | (F df) | ||||
(SD) | (SD) | |||||
Back pain/10 | Pre | 5.09 | 5.33 | 0.05 1,80 | 1.41 1,80 | 125.11 1,80(p<0.001) |
(2.28) | (2.18) | (p=0.83) | (p=0.52) | 14.62 1,94 (p<0.001) | ||
Post | 2.41 | 2.33 | ||||
(1.92) | (1.77) | |||||
Leg pain/10** | Pre | 3.27 | 3.11 | 0.01 1,75 | 0.70 1,75 | 63.29 1,75 (p<0.001) |
(2.95) | (3.21) | (p=0.91) | (p=0.41) | 55.12 1,93 (p=0.001) | ||
Post | 1.00 | 1.28 | ||||
(1.86) | (1.99) | |||||
RMDQ: Total yes/24 | Pre | 15.09 | 17.76 | 3.18 1,78 | 0.01 1,78 | 34.61 1,78 (p<0.001) |
(6.75) | (5.90) | (p=0.08) | (p=0.93) | 42.37 1,94 (p<0.001) | ||
Post | 10.96 | 13.50 | ||||
(7.74) | (8.20) | |||||
Medication: Total | Pre | 2.56 | 2.07 | 0.001 1,29 | 1.38 1,29 | 8.24 1,29 (p=0.008) |
pills/day** | (2.76) | (1.83) | (p=0.98) | (p=0.25) | 10.46 1,48 (p=0.002) | |
Post | 0.81 | 1.33 | ||||
(1.33) | (1.76) | |||||
During the past week, | Pre | 3.13 | 3.34 | 1.01 1,79 | 0.04 1,79 | 78.12 1,79 (p<0.001) |
pain interference | (1.09) | (0.97) | (p=0.32) | (p=0.85) | 70.88 1,94 (p=0.001) | |
with usual work, in | Post | 2.17 | 2.34 | |||
and outside home: | (0.85) | (0.99) | ||||
rating (0–5) | ||||||
BDI-11 | Pre | 6.31 | 4.71 | 1.51 1,74 | 0.23 1,74 | 34.19 1,74 (p<0.001) |
(7.16) | (4.17) | (p=0.22) | (p=0.63) | 33.67 1,94 (p=0.001) | ||
Post | 3.74 | 2.53 | ||||
(5.22) | (3.18) | |||||
Taking medication (Yes) | Pre | 10 | 8 | McNemar test used for time effect (p=0.040) | ||
(52.6%) | (66.7%) | Groups collapsed due to small n (p=0.002) | ||||
Post | 6 | 5 | ||||
(31.6%) | (41.7%) |
Opposite = evidence-based advice and exercises opposite to DP; EBC = evidence-based advice and common back exercises; RMDQ = Roland Morris Disability Questionnaire; BDI = Beck Depression Inventory
*Intention-to-treat analysis using carry-forward of last known data point
**Floor effect: those with no leg pain/no medication at baseline were excluded from analysis.